Identifying Novel Blood-Brain Barrier Transport Pathways Beyond TfR and CD98 for CNS Drug Delivery

12:00 pm - Thursday 3rd December 2026

  • Evaluating the limitations of current receptor-mediated shuttle approaches
  • Discovering and validating novel BBB transport mechanisms for therapeutic delivery
  • Developing screening strategies to identify high-potential shuttle targets
  • Translating emerging shuttle candidates from preclinical evaluation into clinical development

Speakers:

Investigator
Novartis